PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 82 filers reported holding PMV PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,643,528 | -2.7% | 919,142 | -0.8% | 0.00% | 0.0% |
| Q2 2023 | $5,801,364 | +32.5% | 926,735 | +1.0% | 0.00% | +33.3% |
| Q1 2023 | $4,378,313 | -43.8% | 917,885 | +2.5% | 0.00% | -50.0% |
| Q4 2022 | $7,794,035 | -30.9% | 895,866 | -5.5% | 0.01% | -33.3% |
| Q3 2022 | $11,280,000 | -3.6% | 947,876 | +15.4% | 0.01% | 0.0% |
| Q2 2022 | $11,702,000 | -9.2% | 821,232 | +32.7% | 0.01% | +12.5% |
| Q1 2022 | $12,886,000 | -6.6% | 618,926 | +3.7% | 0.01% | 0.0% |
| Q4 2021 | $13,790,000 | -5.5% | 596,962 | +21.8% | 0.01% | -20.0% |
| Q3 2021 | $14,600,000 | -7.5% | 489,935 | +6.1% | 0.01% | 0.0% |
| Q2 2021 | $15,779,000 | +141.8% | 461,913 | +132.8% | 0.01% | +100.0% |
| Q1 2021 | $6,526,000 | -46.0% | 198,422 | +1.0% | 0.01% | -44.4% |
| Q4 2020 | $12,084,000 | +69.5% | 196,455 | -2.2% | 0.01% | +50.0% |
| Q3 2020 | $7,128,000 | – | 200,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 3,869,911 | $115,323,000 | 47.76% |
| Euclidean Capital LLC | 2,769,813 | $82,540,000 | 40.12% |
| Logos Global Management LP | 1,400,000 | $41,720,000 | 3.01% |
| Orbimed Advisors | 7,330,423 | $218,447,000 | 2.40% |
| Boxer Capital, LLC | 2,268,236 | $67,593,000 | 2.36% |
| PERSONAL CFO SOLUTIONS, LLC | 355,342 | $10,589,000 | 2.17% |
| Asymmetry Capital Management, L.P. | 100,882 | $3,006,000 | 1.81% |
| Avoro Capital Advisors LLC | 2,925,000 | $87,165,000 | 1.37% |
| COMMODORE CAPITAL LP | 125,000 | $3,725,000 | 0.98% |
| HighVista Strategies LLC | 39,777 | $1,185,000 | 0.78% |